📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Author Correction: Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England (2022)

First Author: Amirthalingam G

Attributed to: A UK underpinning platform to study immunology and immunopathology of COVID-19:The UK Coronavirus Immunology Consortium funded by COVID

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-022-28393-7

PubMed Identifier: 35110555

Publication URI: http://europepmc.org/abstract/MED/35110555

Type: Journal Article/Review

Parent Publication: Nature Communications

Issue: 1

ISSN: 2041-1723